查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678668

全球製药契约製造市场：市场规模、份额、趋势分析（按产品、药品、服务、业务规模、工作流程、应用、最终用途、公司规模、地区）、细分市场预测（2025-2030 年）

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Drug, By Service, By Scale of Operation, By Workflow, By Application, By End Use, By Company, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

医药契约製造市场的成长与趋势：

根据Grand View Research, Inc.的新报告，到2030年全球医药契约製造市场规模预计将达2,245.1亿美元。

预计 2025 年至 2030 年期间，市场复合年增长率为 9.84%。该市场的成长机会源于为製药公司提供的优势，例如成本效益、透过契约製造设施简化生产的能力以及专注于核心竞争力的机会。此外，对生技药品、生物相似药、高活性药物成分 (HPAPI) 和个人化医疗的需求不断增长，正在推动市场的发展。

製药公司大力推动新产品创新，导致对临床试验、包装和法规合规性的受託製造厂商(CMO) 服务的需求增加。跨 CMO 的技术集成，例如连续製造、自动化和人工智慧驱动的製程优化，正在进一步加速製药製造。这些创新提高了效率、消除了浪费并提高了产品品质和标准。

由于 CMO 供应商在帮助公司满足 FDA、EMA 和 ICH 的监管要求方面发挥关键作用，预计製药契约製造製造业将在预测期内继续成长。此外，对品牌学名药的需求不断增长也极大地促进了製药契约製造製造业的扩张。随着各种学名药的专利到期，製药公司正在开发新的学名药来满足这一需求。因此，许多製药公司依赖CMO服务来有效率、有效地满足其市场需求。

此外，监管是製药业的关键因素之一，推动了对製药契约製造的需求。 FDA 在确保市场上药品的安全性和有效性方面发挥着至关重要的作用。同样，策略伙伴关係和加速产品发布也在推动市场成长。例如，2024 年 12 月，Lonza 提到扩大其口服生物製药服务产品，以支持创新胶囊公司的独特开发和製造需求。该产品的推出将使患者能够探索创新的给药解决方案，以减轻生物有效性的挑战。

医药契约製造市场：分析概述

  • 2024 年的市场占有率主要由 API 製造领域占据，占 70.68%。该领域的成长可归因于 HPAPI 产量的增加、对持续 API 製造的需求的不断增长、FDA 市场批准的不断扩大以及新产品的推出。
  • 这是因为对于学名药、特殊药物和 HPAPI 的需求不断增加，製药创新不断增加，以及对 CMO 的效率、扩充性和法规遵从性的要求不断提高，这些都进一步推动了市场成长。
  • 慢性病的增加、专利到期数量的增加以及对高性价比药品的需求不断增长，将导致学名药领域在 2024 年占据市场主导地位。
  • 根据业务规模，批量配方部分占据了市场主导地位。到2024年，这一比例将达到88.88%，这得益于批量生产和降低营运成本的关键支援等多种优势。
  • 2024 年，商业领域占据了市场主导地位。该领域的成长归因于各种有助于治疗疾病的产品的不断推出。
  • 根据应用，肿瘤学预计将在 2024 年占据最大的市场占有率。该细分市场受到癌症发病率增加和新药需求的推动。
  • 根据最终用途，製药公司部门在 2024 年占据最大的市场占有率。製药公司正在转向契约製造以降低成本、提高扩充性并缩短时间。 CMO 提供原料药合成、配方和法规遵循的专业知识。外包还使您能够获得先进的技术、灵活的生产能力和优化的全球供应链。
  • 2024 年，小型企业将因员工实力、设备和创业投资资金的增加而占据市场主导地位。
  • 预计亚太地区在预测期内的成长率最快，复合年增长率为 10.80%。由于日本、中国和印度等国家的製药公司和受託製造厂商数量不断增加，亚太地区在预测期内可能会快速成长。此外，与美国相比，该地区拥有成本较低的熟练劳动力，这也是推动市场成长的因素。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章：医药契约製造市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 医药契约製造市场：分析工具
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第 4 章 医药契约製造市场：按服务分類的估计和趋势分析

  • 医药契约製造市场，依服务：细分仪表板
  • 医药契约製造市场（按服务）波动分析
  • 依服务分类（2018-2030 年）
  • API 製造
  • 成品药製造
    • 口服固态
    • 液体
    • 话题
    • 其他的
  • 包装服务

第 5 章：医药契约製造市场：按产品分類的估计和趋势分析

  • 医药契约製造市场，依产品：细分仪表板
  • 医药契约製造市场（依产品划分）：波动分析
  • 按产品（2018 - 2030 年）
  • 小分子
  • 生物製药
    • 单株抗体
    • 疫苗
    • 重组蛋白
    • 其他的

第六章 医药契约製造市场：按药物分类的估计和趋势分析

  • 药品契约製造市场（按药品）：细分仪表板
  • 药品契约製造市场（按药品）：波动分析
  • 按药物分类（2018 - 2030 年）
  • 非专利的
  • 品牌

第七章 医药契约製造市场：依业务规模估计及趋势分析

  • 医药契约製造市场（按业务规模）：细分仪表板
  • 医药契约製造市场依业务规模划分：波动分析
  • 依业务规模（2018-2030 年）
  • 批次
  • 连续的

第 8 章：医药契约製造市场：按工作流程进行的估计和趋势分析

  • 医药契约製造市场，依工作流程：细分仪表板
  • 医药契约製造市场（按工作流程）：变化分析
  • 按工作流程（2018-2030）
  • 临床
    • 临床市场（2018-2030）
  • 商业
    • 商业市场（2018-2030）

第 9 章：医药契约製造市场：按应用进行的估计和趋势分析

  • 医药契约製造市场，按应用：细分仪表板
  • 医药契约製造市场应用：波动分析
  • 按应用分类（2018-2030）
  • 肿瘤学
    • 肿瘤学市场（2018-2030）
  • 感染疾病
    • 感染疾病市场（2018-2030）
  • 神经系统疾病
    • 神经系统疾病市场（2018-2030）
  • 心血管疾病
    • 心血管疾病市场（2018-2030）
  • 代谢紊乱
    • 代谢紊乱市场（2018-2030）
  • 自体免疫疾病
    • 自体免疫疾病市场（2018-2030）
  • 呼吸系统疾病
    • 呼吸系统疾病市场（2018-2030）
  • 眼科
    • 眼科市场（2018-2030）
  • 消化系统疾病
    • 消化系统疾病市场（2018-2030）
  • 荷尔蒙失调
    • 荷尔蒙失调市场（2018-2030）
  • 血液系统疾病
    • 血液学市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第 10 章：医药契约製造市场：按最终用途进行的估计和趋势分析

  • 医药契约製造市场，依最终用途：细分仪表板
  • 按最终用途分類的医药契约製造市场：差异分析
  • 依最终用途分类（2018-2030 年）
  • 製药公司
    • 医药市场（2018-2030）
  • 生技公司
    • 生技公司市场（2018-2030）

第 11 章 医药契约製造市场：依公司规模估计与趋势分析

  • 医药契约製造市场（依公司规模）：细分仪表板
  • 医药契约製造市场（依公司规模）波动分析
  • 按公司规模（2018-2030 年）
  • 小型企业
    • 小型企业市场（2018-2030）
  • 中型企业
    • 中型企业市场（2018-2030）
  • 大型企业
    • 大型企业市场（2018-2030）

第 12 章 医药契约製造市场：按地区分類的估计和趋势分析

  • 各地区市场占有率分析（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 全球市场概况：按地区
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十三章 竞争格局

  • 市场参与企业分类
  • 公司市场占有率分析（2023/24）
  • 公司简介
    • AbbVie Contract Manufacturing
    • Almac Group
    • Boehringer Ingelheim BioXcellence
    • Catalent
    • Dr. Reddy's Laboratories
    • Fareva
    • Fujifilm Diosynth Biotechnologies
    • Jubilant HollisterStier
    • Lonza Group
    • Patheon（Thermo Fisher Scientific）
    • Pfizer CentreOne
    • Prakruti Life Science
    • Recipharm
    • Samsung Biologics
    • Siegfried Holding AG
    • Vetter Pharma
    • WuXi AppTec
Product Code: GVR-4-68040-520-6

Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global pharmaceutical contract manufacturing market size is expected to reach USD 224.51 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 9.84% from 2025 to 2030. Growth in the market can be attributed to benefits offered to pharmaceutical companies, such as cost efficiencies, the ability to leverage contract manufacturing facilities to streamline production, and the opportunity to focus on core competencies. In addition, the market is driven by the increasing demand for biologics, biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and personalized medicine.

The expansion of pharmaceutical companies into new product innovations has led to the increased demand for contract manufacturing organization (CMO) services for clinical trials, packaging, and regulatory compliance. Technological integrations among CMOs, such as continuous manufacturing, automation, and AI-driven process optimization, are further propelling pharmaceutical production. These innovations enhance efficiency, reduce waste, and improve product quality and standards.

The pharmaceutical contract manufacturing industry is expected to experience continued growth during the forecast period, as CMO providers play a crucial role in helping companies meet the regulatory requirements of the FDA, EMA, and ICH. Moreover, the growing demand for both branded and generic drugs is a significant factor in the expansion of the pharmaceutical contract manufacturing industry. As various generic drugs reach patent expiration, pharmaceutical companies are innovating new generic versions to meet this demand. Hence, many of these pharmaceutical companies are relying on CMO services to fulfill market needs efficiently and effectively.

In addition, regulation is one of the significant factors for pharmaceutical products that have fueled the demand for pharmaceutical contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of pharmaceuticals in the market. Likewise, strategic partnerships and accelerating product launches drive market growth. For instance, in December 2024, Lonza mentioned the expansion of its service offering orally delivered biologic therapies to support innovative capsule companies' unique development and manufacturing needs. The product launch will help patients explore innovative delivery solutions to mitigate bioavailability challenges.

Pharmaceutical Contract Manufacturing Market Report Highlights:

  • The API manufacturing segment dominated the market with a share of 70.68% in 2024. Growth in the segment can be attributed to increasing HPAPI production, rising demand for continuous API manufacturing, growing FDA approval for the market, and the launch of new products.
  • Based on product, the small molecule segment held the largest market share in 2024, which is attributed to the increasing demand for generics, specialty drugs, and HPAPIs, and growing innovations of drugs have enhanced the requirement for CMO's efficiency, scalability, and regulatory compliance further driving the market growth.
  • The generics segment dominated the market in 2024 owing to the increasing prevalence of chronic diseases, growing patent expirations, and rising demand for cost-efficient drugs.
  • Based on scale of operation, the batch segment dominated the market. It accounted for 88.88% in 2024, attributing to various benefits such as batch production and major support for saving operational costs.
  • The commercial segment dominated the market in 2024. Growth in this segment can be attributed to the increasing launch of various products that help treat diseases.
  • The oncology segment held the largest market share in 2024 based on application. This segment is driven by increasing cancer incidences and new pharmaceutical drug requirements.
  • The pharmaceutical companies segment held the largest market share in 2024 based on end-use. Pharmaceutical companies utilize contract manufacturing to lower costs, increase scalability, and speed up time-to-market. CMOs offer expertise in API synthesis, formulation, and regulatory compliance. In addition, outsourcing provides access to advanced technologies, flexible production capacity, and optimized global supply chains.
  • The small company size segment dominated the market in 2024 due to increasing employee strengths, facilities, and venture funding.
  • Asia Pacific is expected to register the fastest growth rate of 10.80% CAGR over the forecast period. Due to the rising number of pharmaceutical companies & contract manufacturing organizations in countries like Japan, China, and India, Asia Pacific will likely witness rapid growth over the estimated time. Furthermore, the availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Product
    • 1.2.3. Drug
    • 1.2.4. Scale of Operation
    • 1.2.5. Workflow
    • 1.2.6. Application
    • 1.2.7. End Use
    • 1.2.8. Company Size
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Advancements
  • 3.4. Clinical trials volume analysis (2024)
  • 3.5. Pharmaceutical Contract Manufacturing Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's Five Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Contract Manufacturing Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Contract Manufacturing Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030
  • 4.4. API Manufacturing
    • 4.4.1. API Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Finished Drug Product Manufacturing
    • 4.5.1. Finished Drug Product Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Oral Solids
      • 4.5.2.1. Oral Solids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Liquids
      • 4.5.3.1. Liquids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Topical
      • 4.5.4.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Packaging Services
    • 4.6.1. Packaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 5.1. Pharmaceutical Contract Manufacturing Market, By Product: Segment Dashboard
  • 5.2. Pharmaceutical Contract Manufacturing Market, By Product: Movement Analysis
  • 5.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030
  • 5.4. Small Molecule
    • 5.4.1. Small Molecule Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biologics
    • 5.5.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Monoclonal Antibodies
      • 5.5.2.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Vaccines
      • 5.5.3.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Recombinant Proteins
      • 5.5.4.1. Recombinant Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Manufacturing Market: Drug Estimates & Trend Analysis

  • 6.1. Pharmaceutical Contract Manufacturing Market, By Drug: Segment Dashboard
  • 6.2. Pharmaceutical Contract Manufacturing Market, By Drug: Movement Analysis
  • 6.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Drug, 2018 - 2030
  • 6.4. Generics
    • 6.4.1. Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Branded
    • 6.5.1. Branded Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis

  • 7.1. Pharmaceutical Contract Manufacturing Market, By Scale of Operation: Segment Dashboard
  • 7.2. Pharmaceutical Contract Manufacturing Market, By Scale of Operation: Movement Analysis
  • 7.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Scale of Operation, 2018 - 2030
  • 7.4. Batch
    • 7.4.1. Batch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Continuous
    • 7.5.1. Continuous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Pharmaceutical Contract Manufacturing Market: Workflow Estimates & Trend Analysis

  • 8.1. Pharmaceutical Contract Manufacturing Market, By Workflow: Segment Dashboard
  • 8.2. Pharmaceutical Contract Manufacturing Market, By Workflow: Movement Analysis
  • 8.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Workflow, 2018 - 2030
  • 8.4. Clinical
    • 8.4.1. Clinical Market, 2018 to 2030, (USD Million)
  • 8.5. Commercial
    • 8.5.1. Commercial Market, 2018 to 2030, (USD Million)

Chapter 9. Pharmaceutical Contract Manufacturing Market: Application Estimates & Trend Analysis

  • 9.1. Pharmaceutical Contract Manufacturing Market, By Application: Segment Dashboard
  • 9.2. Pharmaceutical Contract Manufacturing Market, By Application: Movement Analysis
  • 9.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Application, 2018 - 2030
  • 9.4. Oncology
    • 9.4.1. Oncology Market, 2018 to 2030, (USD Million)
  • 9.5. Infectious Diseases
    • 9.5.1. Infectious Diseases Market, 2018 to 2030, (USD Million)
  • 9.6. Neurological Disorders
    • 9.6.1. Neurological Disorders Market, 2018 to 2030, (USD Million)
  • 9.7. Cardiovascular Disease
    • 9.7.1. Cardiovascular Disease Market, 2018 to 2030, (USD Million)
  • 9.8. Metabolic Disorders
    • 9.8.1. Metabolic Disorders Market, 2018 to 2030, (USD Million)
  • 9.9. Autoimmune Diseases
    • 9.9.1. Autoimmune Diseases Market, 2018 to 2030, (USD Million)
  • 9.10. Respiratory Diseases
    • 9.10.1. Respiratory Diseases Market, 2018 to 2030, (USD Million)
  • 9.11. Ophthalmology
    • 9.11.1. Ophthalmology Market, 2018 to 2030, (USD Million)
  • 9.12. Gastrointestinal Disorders
    • 9.12.1. Gastrointestinal Disorders Market, 2018 to 2030, (USD Million)
  • 9.13. Hormonal Disorders
    • 9.13.1. Hormonal Disorders Market, 2018 to 2030, (USD Million)
  • 9.14. Hematological Disorders
    • 9.14.1. Hematological Disorders Market, 2018 to 2030, (USD Million)
  • 9.15. Others
    • 9.15.1. Others Market, 2018 to 2030, (USD Million)

Chapter 10. Pharmaceutical Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 10.1. Pharmaceutical Contract Manufacturing Market, By End Use: Segment Dashboard
  • 10.2. Pharmaceutical Contract Manufacturing Market, By End Use: Movement Analysis
  • 10.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030
  • 10.4. Pharmaceutical Companies
    • 10.4.1. Pharmaceutical Companies Market, 2018 to 2030, (USD Million)
  • 10.5. Biotechnology Companies
    • 10.5.1. Biotechnology Companies Market, 2018 to 2030, (USD Million)

Chapter 11. Pharmaceutical Contract Manufacturing Market: Company Size Estimates & Trend Analysis

  • 11.1. Pharmaceutical Contract Manufacturing Market, By Company Size: Segment Dashboard
  • 11.2. Pharmaceutical Contract Manufacturing Market, By Company Size: Movement Analysis
  • 11.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, By Company Size, 2018 - 2030
  • 11.4. Small
    • 11.4.1. Small Market, 2018 to 2030, (USD Million)
  • 11.5. Medium
    • 11.5.1. Medium Market, 2018 to 2030, (USD Million)
  • 11.6. Large
    • 11.6.1. Large Market, 2018 to 2030, (USD Million)

Chapter 12. Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 12.1. Regional Market Share Analysis, 2024 & 2030
  • 12.2. Regional Market Dashboard
  • 12.3. Global Regional Market Snapshot
  • 12.4. North America
    • 12.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.4.2. U.S
      • 12.4.2.1. Key Country Dynamics
      • 12.4.2.2. Competitive Scenario
      • 12.4.2.3. Regulatory Framework
      • 12.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.4.3. Canada
      • 12.4.3.1. Key Country Dynamics
      • 12.4.3.2. Competitive Scenario
      • 12.4.3.3. Regulatory Framework
      • 12.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.4.4. Mexico
      • 12.4.4.1. Key Country Dynamics
      • 12.4.4.2. Competitive Scenario
      • 12.4.4.3. Regulatory Framework
      • 12.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.5. Europe
    • 12.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.2. UK
      • 12.5.2.1. Key Country Dynamics
      • 12.5.2.2. Competitive Scenario
      • 12.5.2.3. Regulatory Framework
      • 12.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.3. Germany
      • 12.5.3.1. Key Country Dynamics
      • 12.5.3.2. Competitive Scenario
      • 12.5.3.3. Regulatory Framework
      • 12.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.4. France
      • 12.5.4.1. Key Country Dynamics
      • 12.5.4.2. Competitive Scenario
      • 12.5.4.3. Regulatory Framework
      • 12.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.5. Italy
      • 12.5.5.1. Key Country Dynamics
      • 12.5.5.2. Competitive Scenario
      • 12.5.5.3. Regulatory Framework
      • 12.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.6. Spain
      • 12.5.6.1. Key Country Dynamics
      • 12.5.6.2. Competitive Scenario
      • 12.5.6.3. Regulatory Framework
      • 12.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.7. Denmark
      • 12.5.7.1. Key Country Dynamics
      • 12.5.7.2. Competitive Scenario
      • 12.5.7.3. Regulatory Framework
      • 12.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.8. Sweden
      • 12.5.8.1. Key Country Dynamics
      • 12.5.8.2. Competitive Scenario
      • 12.5.8.3. Regulatory Framework
      • 12.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.5.9. Norway
      • 12.5.9.1. Key Country Dynamics
      • 12.5.9.2. Competitive Scenario
      • 12.5.9.3. Regulatory Framework
      • 12.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.6. Asia Pacific
    • 12.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.2. Japan
      • 12.6.2.1. Key Country Dynamics
      • 12.6.2.2. Competitive Scenario
      • 12.6.2.3. Regulatory Framework
      • 12.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.3. China
      • 12.6.3.1. Key Country Dynamics
      • 12.6.3.2. Competitive Scenario
      • 12.6.3.3. Regulatory Framework
      • 12.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.4. India
      • 12.6.4.1. Key Country Dynamics
      • 12.6.4.2. Competitive Scenario
      • 12.6.4.3. Regulatory Framework
      • 12.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.5. Thailand
      • 12.6.5.1. Key Country Dynamics
      • 12.6.5.2. Competitive Scenario
      • 12.6.5.3. Regulatory Framework
      • 12.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.6. South Korea
      • 12.6.6.1. Key Country Dynamics
      • 12.6.6.2. Competitive Scenario
      • 12.6.6.3. Regulatory Framework
      • 12.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.6.7. Australia
      • 12.6.7.1. Key Country Dynamics
      • 12.6.7.2. Competitive Scenario
      • 12.6.7.3. Regulatory Framework
      • 12.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.7. Latin America
    • 12.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.7.2. Brazil
      • 12.7.2.1. Key Country Dynamics
      • 12.7.2.2. Competitive Scenario
      • 12.7.2.3. Regulatory Framework
      • 12.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.7.3. Argentina
      • 12.7.3.1. Key Country Dynamics
      • 12.7.3.2. Competitive Scenario
      • 12.7.3.3. Regulatory Framework
      • 12.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 12.8. MEA
    • 12.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.2. South Africa
      • 12.8.2.1. Key Country Dynamics
      • 12.8.2.2. Competitive Scenario
      • 12.8.2.3. Regulatory Framework
      • 12.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.3. Saudi Arabia
      • 12.8.3.1. Key Country Dynamics
      • 12.8.3.2. Competitive Scenario
      • 12.8.3.3. Regulatory Framework
      • 12.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.4. UAE
      • 12.8.4.1. Key Country Dynamics
      • 12.8.4.2. Competitive Scenario
      • 12.8.4.3. Regulatory Framework
      • 12.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 12.8.5. Kuwait
      • 12.8.5.1. Key Country Dynamics
      • 12.8.5.2. Competitive Scenario
      • 12.8.5.3. Regulatory Framework
      • 12.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 13. Competitive Landscape

  • 13.1. Market Participant Categorization
  • 13.2. Company Market Share Analysis, 2023/24
  • 13.3. Company Profiles
    • 13.3.1. AbbVie Contract Manufacturing
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Financial Performance
      • 13.3.1.3. Service Benchmarking
      • 13.3.1.4. Strategic Initiatives
    • 13.3.2. Almac Group
      • 13.3.2.1. Company Overview
      • 13.3.2.2. Financial Performance
      • 13.3.2.3. Service Benchmarking
      • 13.3.2.4. Strategic Initiatives
    • 13.3.3. Boehringer Ingelheim BioXcellence
      • 13.3.3.1. Company Overview
      • 13.3.3.2. Financial Performance
      • 13.3.3.3. Service Benchmarking
      • 13.3.3.4. Strategic Initiatives
    • 13.3.4. Catalent
      • 13.3.4.1. Company Overview
      • 13.3.4.2. Financial Performance
      • 13.3.4.3. Service Benchmarking
      • 13.3.4.4. Strategic Initiatives
    • 13.3.5. Dr. Reddy's Laboratories
      • 13.3.5.1. Company Overview
      • 13.3.5.2. Financial Performance
      • 13.3.5.3. Service Benchmarking
      • 13.3.5.4. Strategic Initiatives
    • 13.3.6. Fareva
      • 13.3.6.1. Company Overview
      • 13.3.6.2. Financial Performance
      • 13.3.6.3. Service Benchmarking
      • 13.3.6.4. Strategic Initiatives
    • 13.3.7. Fujifilm Diosynth Biotechnologies
      • 13.3.7.1. Company Overview
      • 13.3.7.2. Financial Performance
      • 13.3.7.3. Service Benchmarking
      • 13.3.7.4. Strategic Initiatives
    • 13.3.8. Jubilant HollisterStier
      • 13.3.8.1. Company Overview
      • 13.3.8.2. Financial Performance
      • 13.3.8.3. Service Benchmarking
      • 13.3.8.4. Strategic Initiatives
    • 13.3.9. Lonza Group
      • 13.3.9.1. Company Overview
      • 13.3.9.2. Financial Performance
      • 13.3.9.3. Service Benchmarking
      • 13.3.9.4. Strategic Initiatives
    • 13.3.10. Patheon (Thermo Fisher Scientific)
      • 13.3.10.1. Company Overview
      • 13.3.10.2. Financial Performance
      • 13.3.10.3. Service Benchmarking
      • 13.3.10.4. Strategic Initiatives
    • 13.3.11. Pfizer CentreOne
      • 13.3.11.1. Company Overview
      • 13.3.11.2. Financial Performance
      • 13.3.11.3. Service Benchmarking
      • 13.3.11.4. Strategic Initiatives
    • 13.3.12. Prakruti Life Science
      • 13.3.12.1. Company Overview
      • 13.3.12.2. Financial Performance
      • 13.3.12.3. Service Benchmarking
      • 13.3.12.4. Strategic Initiatives
    • 13.3.13. Recipharm
      • 13.3.13.1. Company Overview
      • 13.3.13.2. Financial Performance
      • 13.3.13.3. Service Benchmarking
      • 13.3.13.4. Strategic Initiatives
    • 13.3.14. Samsung Biologics
      • 13.3.14.1. Company Overview
      • 13.3.14.2. Financial Performance
      • 13.3.14.3. Service Benchmarking
      • 13.3.14.4. Strategic Initiatives
    • 13.3.15. Siegfried Holding AG
      • 13.3.15.1. Company Overview
      • 13.3.15.2. Financial Performance
      • 13.3.15.3. Service Benchmarking
      • 13.3.15.4. Strategic Initiatives
    • 13.3.16. Vetter Pharma
      • 13.3.16.1. Company Overview
      • 13.3.16.2. Financial Performance
      • 13.3.16.3. Service Benchmarking
      • 13.3.16.4. Strategic Initiatives
    • 13.3.17. WuXi AppTec
      • 13.3.17.1. Company Overview
      • 13.3.17.2. Financial Performance
      • 13.3.17.3. Service Benchmarking
      • 13.3.17.4. Strategic Initiatives

List of Tables

  • Table. 1 List of Secondary Sources
  • Table. 2 List of Abbreviations
  • Table. 3 Global Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 4 Global Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 5 Global Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 6 Global Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 7 Global Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 8 Global Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 9 Global Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 10 Global Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 11 North America Pharmaceutical Contract Manufacturing Market, by Country, 2018 - 2030 (USD Million)
  • Table. 12 North America Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 13 North America Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 14 North America Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 15 North America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 16 North America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 17 North America Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 18 North America Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 19 North America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 20 U.S. Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 21 U.S. Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 22 U.S. Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 23 U.S. Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 24 U.S. Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 25 U.S. Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 26 U.S. Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 27 U.S. Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 28 Canada Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 29 Canada Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 30 Canada Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 31 Canada Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 32 Canada Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 33 Canada Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 34 Canada Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 35 Canada Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 36 Mexico Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 37 Mexico Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 38 Mexico Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 39 Mexico Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 40 Mexico Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 41 Mexico Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 42 Mexico Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 43 Mexico Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 44 Europe Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 45 Europe Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 46 Europe Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 47 Europe Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 48 Europe Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 49 Europe Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 50 Europe Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 51 Europe Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 52 Europe Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 53 UK Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 54 UK Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 55 UK Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 56 UK Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 57 UK Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 58 UK Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 59 UK Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 60 UK Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 61 Germany Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 62 Germany Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 63 Germany Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 64 Germany Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 65 Germany Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 66 Germany Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 67 Germany Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 68 Germany Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 69 France Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 70 France Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 71 France Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 72 France Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 73 France Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 74 France Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 75 France Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 76 France Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 77 Italy Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 78 Italy Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 79 Italy Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 80 Italy Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 81 Italy Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 82 Italy Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 83 Italy Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 84 Italy Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 85 Spain Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 86 Spain Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 87 Spain Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 88 Spain Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 89 Spain Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 90 Spain Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 91 Spain Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 92 Spain Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 93 Denmark Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 94 Denmark Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 95 Denmark Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 96 Denmark Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 97 Denmark Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 98 Denmark Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 99 Denmark Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 100 Denmark Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 101 Sweden Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 102 Sweden Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 103 Sweden Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 104 Sweden Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 105 Sweden Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 106 Sweden Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 107 Sweden Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 108 Sweden Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 109 Norway Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 110 Norway Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 111 Norway Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 112 Norway Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 113 Norway Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 114 Norway Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 115 Norway Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 116 Norway Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 117 Asia Pacific Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 118 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 119 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 120 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 121 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 122 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 123 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 124 Asia Pacific Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 125 Asia Pacific Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 126 Japan Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 127 Japan Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 128 Japan Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 129 Japan Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 130 Japan Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 131 Japan Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 132 Japan Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 133 Japan Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 134 China Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 135 China Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 136 China Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 137 China Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 138 China Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 139 China Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 140 China Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 141 China Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 142 India Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 143 India Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 144 India Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 145 India Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 146 India Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 147 India Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 148 India Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 149 India Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 150 Thailand Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 151 Thailand Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 152 Thailand Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 153 Thailand Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 154 Thailand Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 155 Thailand Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 156 Thailand Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 157 Thailand Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 158 South Korea Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 159 South Korea Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 160 South Korea Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 161 South Korea Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 162 South Korea Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 163 South Korea Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 164 South Korea Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 165 South Korea Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 166 Australia Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 167 Australia Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 168 Australia Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 169 Australia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 170 Australia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 171 Australia Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 172 Australia Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 173 Australia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 174 Latin America Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 175 Latin America Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 176 Latin America Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 177 Latin America Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 178 Latin America Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 179 Latin America Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 180 Latin America Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 181 Latin America Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 182 Latin America Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 183 Brazil Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 184 Brazil Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 185 Brazil Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 186 Brazil Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 187 Brazil Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 188 Brazil Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 189 Brazil Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 190 Brazil Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 191 Argentina Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 192 Argentina Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 193 Argentina Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 194 Argentina Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 195 Argentina Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 196 Argentina Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 197 Argentina Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 198 Argentina Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 199 Middle East & Africa Pharmaceutical Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Table. 200 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 201 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 202 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 203 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 204 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 205 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 206 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 207 Middle East & Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 208 South Africa Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 209 South Africa Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 210 South Africa Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 211 South Africa Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 212 South Africa Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 213 South Africa Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 214 South Africa Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 215 South Africa Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 216 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 217 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 218 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 219 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 220 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 221 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 222 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 223 Saudi Arabia Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 224 UAE Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 225 UAE Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 226 UAE Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 227 UAE Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 228 UAE Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 229 UAE Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 230 UAE Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 231 UAE Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 (USD Million)
  • Table. 232 Kuwait Pharmaceutical Contract Manufacturing Market, by Service, 2018 - 2030 (USD Million)
  • Table. 233 Kuwait Pharmaceutical Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table. 234 Kuwait Pharmaceutical Contract Manufacturing Market, by Drug, 2018 - 2030 (USD Million)
  • Table. 235 Kuwait Pharmaceutical Contract Manufacturing Market, by Scale of Operation, 2018 - 2030 (USD Million)
  • Table. 236 Kuwait Pharmaceutical Contract Manufacturing Market, by Workflow, 2018 - 2030 (USD Million)
  • Table. 237 Kuwait Pharmaceutical Contract Manufacturing Market, by Application, 2018 - 2030 (USD Million)
  • Table. 238 Kuwait Pharmaceutical Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 239 Kuwait Pharmaceutical Contract Manufacturing Market, by Company Size, 2018 - 2030 ((USD Million)
  • Table. 240 Financial performance

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Contract Manufacturing Market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Contract Manufacturing Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Contract Manufacturing Market: Service movement analysis
  • Fig. 21 API manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Finished drug product manufacturing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Oral solids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Liquids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Packaging services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical Contract Manufacturing Market: Product outlook and key takeaways
  • Fig. 29 Pharmaceutical Contract Manufacturing Market: Product movement analysis
  • Fig. 30 Small molecule market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Vaccines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Recombinant proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Contract Manufacturing Market: Drug outlook and key takeaways
  • Fig. 37 Pharmaceutical Contract Manufacturing Market: Drug movement analysis
  • Fig. 38 Generics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Branded market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Pharmaceutical Contract Manufacturing Market: Scale of operation outlook and key takeaways
  • Fig. 41 Pharmaceutical Contract Manufacturing Market: Scale of operation movement analysis
  • Fig. 42 Batch market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Continuous market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceutical Contract Manufacturing Market: Workflow outlook and key takeaways
  • Fig. 45 Pharmaceutical Contract Manufacturing Market: Workflow movement analysis
  • Fig. 46 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Commercial market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Pharmaceutical Contract Manufacturing Market: Application outlook and key takeaways
  • Fig. 49 Pharmaceutical Contract Manufacturing Market: Application movement analysis
  • Fig. 50 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Cardiovascular disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Hormonal disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Hematological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Pharmaceutical Contract Manufacturing Market: End Use outlook and key takeaways
  • Fig. 63 Pharmaceutical Contract Manufacturing Market: End Use movement analysis
  • Fig. 64 Pharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Pharmaceutical Contract Manufacturing Market: Company Size outlook and key takeaways
  • Fig. 67 Pharmaceutical Contract Manufacturing Market: Company Size movement analysis
  • Fig. 68 Small market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Medium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Large market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Regional Marketplace: Key Takeaways
  • Fig. 72 North America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 U.S. Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Canada Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Mexico Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Europe Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 UK Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Germany Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 France Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Italy Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Spain Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Denmark outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Sweden outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Norway outsourcing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Asia Pacific Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Japan Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 China Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 India Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Thailand Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 South Korea Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Australia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Latin America Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Brazil Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Argentina Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 MEA Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 South Africa Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Fig. Key country dynamics
  • Fig. 118 Saudi Arabia Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 UAE Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Kuwait Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Key company categorization
  • Fig. 124 Service heat map analysis
  • Fig. 125 Strategic framework